Table 3. Correlation between AR expression and clinical features.
Clinical features | Statistical test and results |
---|---|
Days to death or last follow up | Logrank P=0.787 Q = 0.920 |
Years to birth | Spearman Correlation R=0.1105 P=0.01132 Q = 0.0765 |
Gender | Wilcoxon test P = 0.8432 Q= 0.971 |
Radiation therapy | Wilcoxon test P = 0.895 Q= 0.98 |
Karnofsky performance score | Spearman Correlation R= -0.0978 P= 0.05173 Q= 0.324 |
Race | Kruskal wallis P =0.2541 Q=1 |
Ethnicity | Wilcoxon test P = 0.351 Q= 0.952 |
Significance (bold) when P value < 0.05 and Q value (False Discovery Rate) < 0.3.
A table drawn from the analysis made by the Broad Institute TCGA Genome Data Analysis Center [11] showing the results of the association between the clinical features and AR expression across 519 tumor samples according to the statistical methods used.